跳至主要内容
临床试验/NCT07709169
NCT07709169已完成不适用

Some Epidemiological Features and Clinical Profile of Psoriasis and Its Impact on Quality of Life Among Psoriatic Patients Attending Tanta University Hospitals

Tanta University1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2023年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
170
试验地点
1
主要终点
Dermatology Life Quality Index (DLQI)

研究概览

简要总结

This work aimed to study some epidemiological features and the clinical profile of patients having psoriasis visiting the Dermatology and Venereology departments of Tanta University Hospitals and to assess the impact of disease on their quality of life.

详细描述

Psoriasis is a genetically determined, systemic immune-mediated inflammatory disease that affects predominantly the skin and joints. It is now recognized as a systemic disease, which is associated with multiple comorbidities, including diabetes, hypertension, obesity, and major cardiovascular adverse events. These can shorten the lifespan of patients with severe disease by up to 5 years.

The presentation of psoriasis varies from dusky red scaly papules to raised plaques on the elbows, knees, or scalp to superficial pustules dispersed on the palms or soles or, in rare cases, widespread pustules all over the body. The plaque, guttate, small plaque, inverse, erythrodermic, and pustular forms of psoriasis are among the clinical spectrum's variants. Psoriasis can be diagnosed clinically. However, a skin biopsy may be required for cases in which the presentation is not typical.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Psoriatic patients of both genders aged ≥18 years old.
  • Patients accepted to be enrolled in this study.

排除标准

  • - Patients below 18 years old.

结局指标

主要结局

Dermatology Life Quality Index (DLQI)

时间窗: Six months after the survey.

Patients completed the Dermatology Life Quality Index (DLQI), which includes 10 questions and is designed for use in adults. Each question is scored on a 4-point scale from 0 ("Not at all") to 3 ("Very much") to assess the past seven days, providing a total score ranging from 0 to 30: 0 - 1: No effect at all on patient's life. 2 - 5: Small effect on patient's life. 6 - 10: Moderate effect on patient's life. 11 - 20: Very large effect on patient's life. 21 - 30: Extremely large effect on patient's life.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hagar Atteya Al-Sharnoby

Lecturer of Dermatology and Venereology, Faculty of Medicine, Tanta University, Egypt

Tanta University

研究点 (1)

Loading locations...

相似试验